FuJian DaHong Industry & Development Co.,Ltd. – Trademark Portfolio

Entity Type: 16

FuJian DaHong Industry & Development Co.,Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include PGTDH. The owner is based in ShiShi City,FuJian,.

Park, High-Tech Development Zone,

ShiShi City,FuJian, 362000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PGTDH
PGTDH
Registered 2020

Trademark Classifications

FuJian DaHong Industry & Development Co.,Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does FuJian DaHong Industry & Development Co.,Ltd. have?

FuJian DaHong Industry & Development Co.,Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does FuJian DaHong Industry & Development Co.,Ltd. file in?

FuJian DaHong Industry & Development Co.,Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are FuJian DaHong Industry & Development Co.,Ltd.'s most well-known trademarks?

FuJian DaHong Industry & Development Co.,Ltd.'s registered trademark portfolio includes well-known marks such as PGTDH. These are among 1 currently registered trademark in the portfolio.

What is FuJian DaHong Industry & Development Co.,Ltd.'s trademark registration success rate?

FuJian DaHong Industry & Development Co.,Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.